rolapitant Varubi
Selected indexed studies
- Rolapitant. (, 2012) [PMID:31643534]
- Rolapitant: first global approval. (Drugs, 2015) [PMID:26467681]
- Rolapitant. (, 2006) [PMID:39836800]
_Worker-drafted node — pending editorial review._
Connections
rolapitant Varubi is a side effect of
Sources
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. (2020) pubmed
- Antiemetic Agents. (2012) pubmed
- Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis. (2021) pubmed
- Rolapitant. (2012) pubmed
- Rolapitant. (2006) pubmed
- Rolapitant: first global approval. (2015) pubmed
- Rolapitant Is a Reversible Inhibitor of CYP2D6. (2019) pubmed
- Rolapitant: A Review in Chemotherapy-Induced Nausea and Vomiting. (2017) pubmed
- Rolapitant (Varubi) for prevention and delayed chemotherapy-induced nausea and vomiting. (2016) pubmed
- Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride. (2018) pubmed